Tian Y - Search Results

1

The long non-coding RNA SNHG3 functions as a competing endogenous RNA to promote malignant development of colorectal cancer.

Huang W, Tian Y, Dong S, Cha Y, Li J, Guo X, Yuan X. Huang W, et al. Among authors: tian y. Oncol Rep. 2017 Sep;38(3):1402-1410. doi: 10.3892/or.2017.5837. Epub 2017 Jul 18. Oncol Rep. 2017. PMID: 28731158 Free PMC article.

2

Oligometastases in AJCC stage IVc nasopharyngeal carcinoma: A subset with better overall survival.

Tian YH, Zou WH, Xiao WW, Zeng L, Yuan X, Bai L, Lu T, Tian Y, Han F. Tian YH, et al. Among authors: tian y. Head Neck. 2016 Aug;38(8):1152-7. doi: 10.1002/hed.24345. Epub 2016 May 24. Head Neck. 2016. PMID: 27220062

3

The challenge in treating locally recurrent T3-4 nasopharyngeal carcinoma: the survival benefit and severe late toxicities of re-irradiation with intensity-modulated radiotherapy.

Tian YM, Huang WZ, Yuan X, Bai L, Zhao C, Han F. Tian YM, et al. Oncotarget. 2017 Jun 27;8(26):43450-43457. doi: 10.18632/oncotarget.15896. Oncotarget. 2017. PMID: 28427216 Free PMC article.

4

The Value of Cervical Node Features in Predicting Long-Term Survival of Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy Era.

Tian YM, Zeng L, Lan YH, Yuan X, Bai L, Han F. Tian YM, et al. Cancer Manag Res. 2021 Jun 21;13:4899-4909. doi: 10.2147/CMAR.S312161. eCollection 2021. Cancer Manag Res. 2021. PMID: 34188543 Free PMC article.

5

Efficacy and safety analysis of bevacizumab combined with capecitabine in the maintenance treatment of RAS-mutant metastatic colorectal cancer.

Huang W, Zhang H, Tian Y, Cha Y, Xiong H, Yuan X. Huang W, et al. Among authors: tian y. J Clin Pharm Ther. 2022 Apr;47(4):531-538. doi: 10.1111/jcpt.13576. Epub 2022 Feb 25. J Clin Pharm Ther. 2022. PMID: 35218209 Free PMC article.

6

LncRNA SNHG11 enhances bevacizumab resistance in colorectal cancer by mediating miR-1207-5p/ABCC1 axis.

Huang W, Zhang H, Tian Y, Li Y, Li J, Zhong X, Yuan X. Huang W, et al. Among authors: tian y. Anticancer Drugs. 2022 Jul 1;33(6):575-586. doi: 10.1097/CAD.0000000000001289. Epub 2022 Mar 23. Anticancer Drugs. 2022. PMID: 35324517

7

Junctional adhesion molecule-A, an epithelial-mesenchymal transition inducer, correlates with metastasis and poor prognosis in human nasopharyngeal cancer.

Tian Y, Tian Y, Zhang W, Wei F, Yang J, Luo X, Zhou T, Hou B, Qian S, Deng X, Qiu Y, Yao K. Tian Y, et al. Carcinogenesis. 2015 Jan;36(1):41-8. doi: 10.1093/carcin/bgu230. Epub 2014 Nov 21. Carcinogenesis. 2015. PMID: 25416560

8

miR156a Mimic Represses the Epithelial-Mesenchymal Transition of Human Nasopharyngeal Cancer Cells by Targeting Junctional Adhesion Molecule A.

Tian Y, Cai L, Tian Y, Tu Y, Qiu H, Xie G, Huang D, Zheng R, Zhang W. Tian Y, et al. PLoS One. 2016 Jun 24;11(6):e0157686. doi: 10.1371/journal.pone.0157686. eCollection 2016. PLoS One. 2016. PMID: 27341697 Free PMC article.

9

Prognostic model and optimal treatment for patients with stage IVc nasopharyngeal carcinoma at diagnosis.

Tian YM, Huang WZ, Lan YH, Zhao C, Bai L, Han F. Tian YM, et al. Sci Rep. 2019 Dec 17;9(1):19272. doi: 10.1038/s41598-019-55586-w. Sci Rep. 2019. PMID: 31848409 Free PMC article. Clinical Trial.

10

microRNA-124 inhibits stem-like properties and enhances radiosensitivity in nasopharyngeal carcinoma cells via direct repression of expression of JAMA.

Tian Y, Tian Y, Tu Y, Zhang G, Zeng X, Lin J, Ai M, Mao Z, Zheng R, Yuan Y. Tian Y, et al. J Cell Mol Med. 2020 Sep;24(17):9533-9544. doi: 10.1111/jcmm.15177. Epub 2020 Jul 17. J Cell Mol Med. 2020. PMID: 32681617 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,862 results

Search Page

Filters